lanadelumab
Generic: lanadelumab·Brand: Takhzyro
lanadelumab: 1 clinical trial tracked.
lanadelumab evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about lanadelumab, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
Specific Use-Results Survey of TAKHZYRO Subcutaneous Injection 300 mg Syringe for Hereditary Angioedema With Long-term Administration
NCT05397431Registry updated 2026-08-04
Primary endpoint: Number of Participants Who Experienced At Least One Treatment-Emergent Adverse Event (TEAE)
Observational155 enrolledStarted 2022-05Completion 2026-101 site · JapanTakeda